Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing groundbreaking solutions or leading collaborative research projects, our funding directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
Contact us at fundingsupport@lshubwales.com for guidance, bid review and editing, and help finding the perfect opportunity for your project. Last updated: June 2025
The MS Society Catalyst Award provides support over a maximum of 12 months for short-term, small-scale pilot or proof of concept research projects to explore innovative ideas in MS research. Projects should be hypothesis driven and may be 'high-risk, high-reward' in nature.
Support for research teams to build resilience into the delivery of health and social care services through interventions and solutions that are designed to minimise the impact of extreme weather events.
A European Commission prize for academic and research institutions in EU Member States and Horizon Europe associated countries to recognise their achievements in implementing gender equality measures.
Apply for funding to undertake ambitious interdisciplinary research to tackle epidemic diseases of animals, humans or plants for a duration of up to five years.
Apply for funding to run a scheme at your research organisation (RO) to reimburse public partners who work with researchers to develop Medical Research Council (MRC) research funding applications.
Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
Entry Level Scholarships to enable candidates to develop research interests in obstetrics, gynaecology, midwifery, maternity services and women’s reproductive health.
Funding to enable researchers of Black, Bangladeshi and Pakistani heritage in the UK to undertake activities that put them in a stronger position to reach their next career stage.
Funding over a maximum of 18 months to support research focusing on improving rehabilitation and prehabilitation for adults living with low grade brain tumours.
Support for longitudinal dataset projects to develop innovative ways of identifying anxiety, depression and/or psychosis so that, in time, people may benefit from better targeted early interventions.
Funding for joint UK-Australia platform studies (ie multi-arm studies to evaluate multiple interventions) in areas of unmet medical need where there is a pipeline of technologies that justifies such an approach.
Doctoral funding programme for research institutions in the UK to host PhD research projects focusing on the molecular and cellular basis of retinal degeneration.
Fellowships funding over a maximum of three years to support mid-career researchers conducting research that will advance knowledge and understanding of self-harm and suicide.
Projects should aim to develop new methodologies, frameworks, tools, or techniques that benefit health-related research. Proposals must align with Wellcome’s discovery research remit and can be single-discipline or multidisciplinary, spanning areas such as STEM, experimental medicine, clinical and allied health sciences, public health, humanities, and social sciences.
A prize is open to researchers in the UK to recognise sustained excellence in translational neuroscience (neurology and related clinical and academic disciplines).
The Health and Social Care Delivery Research (HSDR) Programme invites research proposals focused on hospital at home services (also referred to as virtual wards) for both adults and children or young people. This funding opportunity supports studies aimed at optimising service design, enhancing equity and delivery, assessing impacts on health and social care systems, and exploring innovative approaches to service integration.
HIS offers research grants to support research projects in the field of healthcare-associated infections (HCAIs) and infection prevention and control in the UK or Ireland. The thematic focus is on translational research.
This award aims to accelerate and drive forward the development of novel drugs for the treatment of Parkinson's. The initiative should provide researchers with the opportunity to generate essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner.
Proposals focusing on optimising the dose of cancer therapies, and that could demonstrate patient benefit through a reduction in side effects or burden of treatment, while maintaining clinical effectiveness.
The Neurosciences and Mental Health Board (NMHB) seeks to advance understanding of the nervous system’s physiology and behaviour across the lifespan, in both health and disease, to improve treatment and prevention of brain disorders. Our research focuses on the connections between the nervous system, brain, mental health, and physical health, as well as how life events influence lifelong neurological and mental wellbeing.
The Sarcoma UK grants programme funds scientific and medical research to investigate the mechanisms of all forms of bone and soft tissue cancers and develop more effective diagnostics and treatments. Its Research Strategy for 2021-2026 aims to ensure everyone affected by sarcoma receives the best treatment, care, information and support available and focuses on researching causes, diagnostics and treatment to improve quality of life, balanced across multiple sarcoma subtypes.
Funding available for projects, including clinical trials, pump priming projects, training and audits, aiming to raise the standards of breast care and breast surgery with clear value to the NHS.
Grant funding over a maximum of five years to support researchers, clinical academics and allied health professionals in the UK conducting research that seeks to better understand and improve the quality of life of people living with cancer, or those who have survived cancer.
RAD's Ignition Fund provides seed funding for exceptional scientists specialising in dementia to support unexpected breakthroughs in their research. The awards are designed to enable scientists to rapidly exploit an opportunity and avoid promising ideas with high potential from being shelved.
The fund seeks to support innovative research that will facilitate a 'stage shift' towards dementia prevention, improved diagnosis, treatment and understanding of the fundamental science of the disease. Applicants do not need any preliminary data in order to apply, but smart and novel new ideas are particularly welcome.
Fellowshipss are available for European and Japanese researchers from any discipline to carry out a research visit in either Japan or Europe, respectively.
A funding model supported by the Vanguard Initiative, which is a collaborative programme supporting industrial modernisation and innovation through industry-led and cross-regional cooperation.
The Health and Social Care Delivery Research (HSDR) Programme seeks to fund high-quality, well-designed research that addresses the needs of NHS and social care leaders. Projects will be conducted by efficient and capable research teams. This is a two-stage, researcher-led funding opportunity. Applicants submit an outline application first; invited candidates then complete a full application at stage two.
What is the clinical and cost-effectiveness of screening for asymptomatic bacteriuria (ASB) in pregnancy? A retrospective study assessing the impact of early pregnancy ASB screening. Applicants should include an internal pilot to confirm data collection feasibility and ensure study completion.
The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer.
Funding for investigator-led research proposals that meet the remit and mission of the BBSRC, including research projects, new facilities or infrastructure provision, pilot projects, proof of concept studies, equipment purchase and research networks.
What is the feasibility, acceptability, effectiveness, and cost-effectiveness of newborn screening for spinal muscular atrophy (SMA)? An appropriately designed study to allow the evaluation of the addition of SMA screening to the newborn blood spot screening programme.
This scheme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.
The ZOLL Foundation is a US-based 501(c)(3) non-profit organisation that was established in 2013 by the ZOLL Medical Corporation. The Foundation provides seed grants for young researchers around the world to support medical research that saves lives. Its scope encompasses a wide range of areas including, but not limited to, emergency medicine, critical care, trauma, cardiovascular health, pulmonary health, neuroscience, and translational research focused on applying discoveries to enhance training and delivery in clinical practice.
Funding to support investigator-initiated studies and education projects, on molecular profiling in oncology and reproductive health, with the aim of increasing high quality molecular profiling for health care providers serving cancer patients and improving clinical outcomes.
Research and Partnership Hubs for a Healthy Society will establish large, multidisciplinary hubs that harness engineering and physical sciences to build strategic research capacity in healthcare technologies. The aim is to support healthier lives through advances in prevention, early diagnosis, and self-management of health.
This Notice of Funding Opportunity (NOFO) supports pilot studies exploring the biological and genetic causes of cancer health disparities. Funding is available for mechanistic research, new models and methods, and secondary data analysis. The NOFO also aims to build a national network of researchers in this field and expand key resources like biospecimens and patient-derived models. Early-stage projects that lay the groundwork for future in-depth studies are encouraged.
This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the National Institutes of Health R03 small grant mechanism. The National Institutes of Health R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following: Pilot or feasibility studies.Secondary analysis of existing data.Small, self-contained research projects.Development of research methodology.Development of new research technology.
Friends for an Earlier Breast Cancer Test (Earlier.org) is a US-based non-profit organisation, established in 1995, that is dedicated exclusively to funding research focused on developing innovative methods for the earlier detection of breast cancer. Its mission is to support the creation of a biological test capable of identifying breast cancer at its earliest stages, potentially even before a tumour has formed. Earlier.org provides funding to support pilot projects that explore new techniques for early breast cancer detection. Grants are intended to provide preliminary data that can lead to more substantial peer-reviewed funding.
This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
